UCG-14032-29147
4 vaccinations
4 coded responses
39 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 430 / OH
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Moderna
- 2020-12-23
- 2020-12-24
- 2020-12-26
- 2020-12-27
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2021-01-06
- 2021-01-13
-
2021-01-20
Dose 2 — Moderna
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Itching · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
-
2021-01-22
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Swelling, Itching · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-02-03
- 2021-02-10
-
2021-02-17
Survey response — day 28, dose 2MedDRA: Injection site pruritus — Feeling: FairFree text: Itching at injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Survey response — day 35, dose 2MedDRA: Injection site pruritus — Feeling: GoodFree text: Itching at injection site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
- 2021-04-21
- 2021-07-21
-
2021-12-27
Dose 3 — Moderna
- 2022-01-20
- 2022-06-27
-
2022-10-13
Dose 4 — Moderna
-
2022-10-14
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Swelling, Itching · NoneAdult check-in
-
2022-10-15
Survey response — days 1–6 daily, dose 4MedDRA: Dizziness — Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2024-11 · check-in free text available
-
2022-10-16
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Redness, Swelling, Itching · NoneAdult check-in
-
2022-10-17
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Swelling, Itching · NoneAdult check-in
-
2022-10-18
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Swelling, Itching · NoneAdult check-in
- 2022-10-19
- 2022-10-20
- 2022-10-27
- 2022-11-03
- 2022-11-12
- 2022-11-17
- 2022-11-24
- 2023-01-12
- 2023-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Moderna | |
| 2 | 2021-01-20 | Moderna | |
| 3 | 2021-12-27 | Moderna | No |
| 4 | 2022-10-13 | Moderna | No |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Release 4 — day 28, dose 2
Symptoms: Itching at injection site.
Release 4 — day 35, dose 2
Symptoms: Itching at injection site.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Dizziness
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release